SEC Info - Capricor Therapeutics, Inc. - ‘S-8’ on 3/4/14

SEC Info℠

Home

Help

Please Sign In

Capricor Therapeutics, Inc. – ‘S-8’ on 3/4/14

On: Tuesday, 3/4/14, at 5:21pm ET · Effective: 3/4/14 · Accession #: 1144204-14-13306 · File #: 333-194317

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/04/14  Capricor Therapeutics, Inc.       S-8         3/04/14   14:648K                                   Vintage/FA

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan — Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML     67K 
                          Employees Pursuant to an Employee                      
                          Benefit Plan                                           
 8: EX-4.10     Instrument Defining the Rights of Security Holders  HTML     58K 
 9: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     13K 
10: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     13K 
11: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     13K 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     81K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     73K 
 4: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     49K 
 5: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     38K 
 6: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     37K 
 7: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     66K 
12: EX-5.1      Opinion re: Legality                                HTML     23K 
13: EX-23.1     Consent of Experts or Counsel                       HTML     10K 
14: EX-23.2     Consent of Experts or Counsel                       HTML     10K

Filing Submission 0001144204-14-013306 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 648K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20140304-172251	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20140304-172251	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20140304-172137	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001144204-14-013306
<TYPE>				S-8
<PUBLIC-DOCUMENT-COUNT>		18
<FILING-DATE>			20140304
<DATE-OF-FILING-DATE-CHANGE>	20140304
<EFFECTIVENESS-DATE>		20140304

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		CAPRICOR THERAPEUTICS, INC.
<CIK>				0001133869
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			000000000
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			S-8
<ACT>				33
<FILE-NUMBER>			333-194317
<FILM-NUMBER>			14666120
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			8840 WILSHIRE BLVD
<STREET2>			2ND FLOOR
<CITY>				BEVERLY HILLS
<STATE>				CA
<ZIP>				90211
<PHONE>				(310) 358-3200
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			8840 WILSHIRE BLVD
<STREET2>			2ND FLOOR
<CITY>				BEVERLY HILLS
<STATE>				CA
<ZIP>				90211
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Nile Therapeutics, Inc.
<DATE-CHANGED>			20070920
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		SMI PRODUCTS INC
<DATE-CHANGED>			20010206
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		S-8
<SEQUENCE>	1
<FILENAME>	v370320_s8.htm
<DESCRIPTION>	FORM S-8
<TEXT>
<HTML>
       Show <HTML>: 1,129 lines (widest: 912 characters) - 78K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.4
<SEQUENCE>	2
<FILENAME>	v370320_ex4-4.htm
<DESCRIPTION>	EXHIBIT 4.4
<TEXT>
<HTML>
       Show <HTML>: 1,259 lines (widest: 317 characters) - 101K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.5
<SEQUENCE>	3
<FILENAME>	v370320_ex4-5.htm
<DESCRIPTION>	EXHIBIT 4.5
<TEXT>
<HTML>
       Show <HTML>: 1,153 lines (widest: 313 characters) - 92K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.6
<SEQUENCE>	4
<FILENAME>	v370320_ex4-6.htm
<DESCRIPTION>	EXHIBIT 4.6
<TEXT>
<HTML>
       Show <HTML>: 764 lines (widest: 240 characters) - 58K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.7
<SEQUENCE>	5
<FILENAME>	v370320_ex4-7.htm
<DESCRIPTION>	EXHIBIT 4.7
<TEXT>
<HTML>
       Show <HTML>: 523 lines (widest: 240 characters) - 39K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.8
<SEQUENCE>	6
<FILENAME>	v370320_ex4-8.htm
<DESCRIPTION>	EXHIBIT 4.8
<TEXT>
<HTML>
       Show <HTML>: 479 lines (widest: 316 characters) - 41K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.9
<SEQUENCE>	7
<FILENAME>	v370320_ex4-9.htm
<DESCRIPTION>	EXHIBIT 4.9
<TEXT>
<HTML>
       Show <HTML>: 1,058 lines (widest: 241 characters) - 84K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.10
<SEQUENCE>	8
<FILENAME>	v370320_ex4-10.htm
<DESCRIPTION>	EXHIBIT 4.10
<TEXT>
<HTML>
       Show <HTML>: 962 lines (widest: 274 characters) - 73K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.11
<SEQUENCE>	9
<FILENAME>	v370320_ex4-11.htm
<DESCRIPTION>	EXHIBIT 4.11
<TEXT>
<HTML>
       Show <HTML>: 141 lines (widest: 240 characters) - 9K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.12
<SEQUENCE>	10
<FILENAME>	v370320_ex4-12.htm
<DESCRIPTION>	EXHIBIT 4.12
<TEXT>
<HTML>
       Show <HTML>: 136 lines (widest: 240 characters) - 9K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.13
<SEQUENCE>	11
<FILENAME>	v370320_ex4-13.htm
<DESCRIPTION>	EXHIBIT 4.13
<TEXT>
<HTML>
       Show <HTML>: 139 lines (widest: 240 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.1
<SEQUENCE>	12
<FILENAME>	v370320_ex5-1.htm
<DESCRIPTION>	EXHIBIT 5.1
<TEXT>
<HTML>
       Show <HTML>: 271 lines (widest: 240 characters) - 21K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-23.1
<SEQUENCE>	13
<FILENAME>	v370320_ex23-1.htm
<DESCRIPTION>	EXHIBIT 23.1
<TEXT>
<HTML>
       Show <HTML>: 87 lines (widest: 727 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-23.2
<SEQUENCE>	14
<FILENAME>	v370320_ex23-2.htm
<DESCRIPTION>	EXHIBIT 23.2
<TEXT>
<HTML>
       Show <HTML>: 71 lines (widest: 240 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	15  ⇐ Not a Document/Exhibit
<FILENAME>	image_001.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 110 lines (Unix-to-Unix encoding) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	16  ⇐ Not a Document/Exhibit
<FILENAME>	image_003.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 64 lines (Unix-to-Unix encoding) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	17  ⇐ Not a Document/Exhibit
<FILENAME>	image_005.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 79 lines (Unix-to-Unix encoding) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	18  ⇐ Not a Document/Exhibit
<FILENAME>	image_007.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 303 lines (Unix-to-Unix encoding) - 19K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001144204-14-013306 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Capricor Therapeutics, Inc. – ‘S-8’ on 3/4/14

On: Tuesday, 3/4/14, at 5:21pm ET · Effective: 3/4/14 · Accession #: 1144204-14-13306 · File #: 333-194317

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan — Form S-8Filing Table of Contents

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan — Form S-8
Filing Table of Contents